Becky E. Zook – Content Creator, Author, Editor, Business Advisor with the Experience, Expertise, Authoritativeness, and Trustworthiness You Need.
Featured Author:
- Textexpander.com
- Inspire.com
- Dermaka.com
- Aesthticveintraining.com
- AllNurses.com
- Nuvissa.com
- Mioca.org
Experience & Expertise
Clinical RN Experience
- Medical, Surgical, and Cardiac ICU
- Chronic Care and Disease Management
- Ambulatory, Rehabilitation, Long-Tern Care
- Homecare & Hospice
- Radiation Oncology in Dermatology
- Vein Surgical Services
- Pathology and Laboratory Services
- Clinical Research Administration
- Government Compliance
- Value-Based Reimbursement
- Telehealth and Electronic Medical Records
- Executive Leadership
Medical and Health Writing Publications
- Chronic and Rare Diseases
- Patient Education Materials and Curriculum
- Health and Wellness
- Medical and Surgical Website Content
- Medical and Health Policy
- Medical and Nursing Leadership
- Systematic Literature Reviews
- Executive Leadership and Coaching
- Organizational Leadership
Clinical Trials Writing
- Protocol Reviews
- Source Documents
- Schedules of Events
- Programming of Clinical Trial Management Systems
- Quality Assurance Documents
- Clinical Research Coordinator Workflows
- Training Presentations
Authoritativeness & Trustworthiness
Education
- Post-Graduate Studies in Organizational Leadership – Northcentral University
- Master of Science in Adult Education and Workforce Development – Pennsylvania State University
- Bachelor of Science in Nursing – Bloomsburg University
RN Licenses
- PA – RN313070-L
- FL – RN 9468058
Certifications
- Stanford University Medical Writing Certificate
- RN2Writer Professional
- EOS Worldwide Rocket Fuel Certified Integrator
- Good Clinical Practice
- Clinical Research Coordinator
- Biosafety and Dangerous Goods
- Shipping of Category A & B Substances
- Responsible Conduct for Research Administrators
Clinical Research Coordinator and Administration Experience
- Amgen: A Study to Investigate Interchangeability of ABP 64 for the Treatment of Participants with Moderate to Severe Plaque Psoriasis.
- Castle Biosciences, Inc.: A Gene Assay Study for Cutaneous Squamous Cell Carcinoma.
- CorEvitasLLC: Corrona Psoriasis Registry.
- Eli Lilly: A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults with Atopic Dermatitis (ADopt-VA).
- Eli Lilly: A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients with Moderate to Severe Atopic Dermatitis.
- Galderma R&D, LLC: A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis.
- Galderma R&D, LLC. : A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab in Subjects with Prurigo Nodularis.
- Galderma R&D, LLC.: Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06089-41) Versus Vehicle Cream for Actinic Keratosis of the Face.
- Mindera Corporation: An Exploratory, Multicenter, Observational Study to Examine RNA Biomarkers of Psoriasis Subjects Through the Application of the Mindera Kit Part 2 (STAMP-2).
- Janssen R&D, LLC: A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Guselkumab for the Treatment of Participants With Skin of Color Who Have Moderate-to-Severe Plaque Psoriasis and/or Moderate-to- Severe Scalp Psoriasis
- Novartis R&D: A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study of Remibrutinib (LOU064) to Investigate the Efficacy, Safety and Tolerability for 52 Weeks in Adult Chronic Spontaneous Urticaria (CSU) Patients Inadequately Controlled by H1- antihistamines.
- Pfizer: A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa
- Sanofi US Services, Inc.: Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2)
- SeraTrials, LLC: Multiple serum and pathology-based studies for Atopic Dermatitis.
- Suzhou Connect Biopharmaceutical, Ltd.: A Randomized, Double-blind, Placebo-controlled Phase 3 Trial to Evaluate the Efficacy and Safety of CBP-201 Monotherapy in Patients With Moderate-To-Severe Atopic Dermatitis Who Are Candidates for Systemic Therapy
- UCB BioPharma: A Phase 3, Open-Label, Parallel Group, Multicenter, Extension Study Evaluating the Long-Term Treatment of Bimekizumab in Study Participants with Moderate to Severe Hidradenitis Suppurativa.
- UCB BioPharma: A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter Study Evaluation the Efficacy and Safety of Bimekizumab in Study Participants with Moderate to Severe Hidrandenitis Suppurativa.
- UCB BioPharma: Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled (12-17 Years) Including a Single Open-Label Arm (6-11 Years) Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Certolizumab Pegol (CZP) in Pediatric Study Participants with Moderate to Severe Chronic Plaque Psoriasis (PSO).
- UCB BioPharma: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa (BE HEARD II)
- Zeltiq Asthetics, Inc., Allergan, and Candela: Multiple Cosmetic Device Trials.
Reviews of Becky Zook
NurseWritersGroup, LLC: Empowering Clinicians with Evidence-Based Medical Content
Using scientific research methods, Zook collects valid and reliable evidence and employs solid writing techniques for search engine optimization algorithms. Modernizing the approach to writing NurseWritersGroup meets the EEAT- Experience, Expertise, Authoritativeness, and Trustworthiness – criteria Google Algorithms require.
We Want to Hear From Our Customers
We value the feedback of our customers. Please click
below to send a testimonial.
- NurseWritersGroup, LLC
